Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
62/100
Pipeline Velocity
36/100
Trial Completion Rate
71/100
Pipeline Concentration
100/100
Pipeline Freshness
78/100
Activity
Last 14 days
A Positive Food Parenting Intervention to Promote Healthy Growth in Children at Risk for Obesity
Friend-based Intervention to Reduce Alcohol-Involved Sexual Assault Risk
The Early Childhood Friendship Project: Testing Key Mechanisms and the Moderating Role of Physiological Reactivity
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
Lowering Food Insecurity and Improving Diabetes With Financial Incentives (LIFT-FINANCE)
Recovery and Outcomes From Stroke-Longitudinal Assessment With Neuroimaging
Dose Response Effect of Nitrous Oxide on Amnesia in Healthy Children
A Family-Based Approach to Treat Obesity and Its Co-morbidities in Youth With Type 1 Diabetes (T1D) and Their Parents
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)